Skip to content

Research at St Andrews

Phenotypic resistance in mycobacteria: is it because I am old or fat that I resist you?

Research output: Contribution to journalArticle

DOI

Open Access permissions

Open

Author(s)

Robert J H Hammond, Vincent O Baron, Katarina Oravcova, Sam Lipworth, Stephen H Gillespie

School/Research organisations

Abstract

Synopsis
Objectives
We aimed to explore the phenomenon of phenotypic resistance to anti-mycobacterial antibiotics and to determine whether this was associated with cell age or presence of lipid bodies.

Methods
The accumulation of lipid body positive cells (lipid rich- LR) was followed using cell staining and flow cytometry. LR cells of M. smegmatis, M. marinum, M. fortuitum and BGC were separated from non-lipid body containing cells (lipid poor- LP) and their MBC determined. We also compared the MBC of LR and LP from “old” and “young” cultures.


Results
The LR cells of all species were more resistant to antibiotics than LP cells. For Mycobacterium bovis (BCG) the susceptibility ratios were as follows; Rifampicin-5X, isoniazid-16.7X, ethambutol-5X, ciprofloxacin-5X. Phenotypic resistance was found in LR cells irrespective of cell age.

Conclusions
We have shown that phenotypic antibiotic resistance is associated with the presence of lipid bodies irrespective of cell age. These data have important implications for our understanding of relapse in mycobacterial infections.

Close

Details

Original languageEnglish
JournalJournal of Antimicrobial Chemotherapy
VolumeAdvance Access
DOIs
StatePublished - 9 Jul 2015

    Research areas

  • Mycobacterium tuberculosis, Antibiotic resistance, Lipid rich, Lipid poor

Discover related content
Find related publications, people, projects and more using interactive charts.

View graph of relations

Related by author

  1. Pseudomonas aeruginosa intensive care unit outbreak: winnowing of transmissions with molecular and genomic typing

    Parcell, B. J., Oravcova, K., Pinheiro, M., Holden, M. T. G., Phillips, G., Turton, J. F. & Gillespie, S. H. 8 Dec 2017 In : Journal of Hospital Infection. In press

    Research output: Contribution to journalArticle

  2. Project Sanitarium: playing tuberculosis to its end game

    Donald, I., Meyer, K., Brengman, J., Gillespie, S. H. & Bowness, R. Dec 2017 In : Journal of Computing in Higher Education. 29, 3, p. 599-617 19 p.

    Research output: Contribution to journalArticle

  3. A comparison of liquid and solid culture for determining relapse and durable cure in phase III TB trials for new regimens

    Phillips, P. P. J., Mendel, C. M., Nunn, A. J., McHugh, T. D., Crook, A. M., Hunt, R., Bateson, A. & Gillespie, S. H. 24 Nov 2017 In : BMC Medicine. 15, 9 p., 207

    Research output: Contribution to journalArticle

  4. Pharmacokinetics, tolerability, and bacteriological response of rifampin administered at 600, 900, and 1,200 milligrams daily in patients with pulmonary tuberculosis

    Aarnoutse, R. E., Kibiki, G. S., Reither, K., Semvua, H. H., Haraka, F., Mtabho, C. M., Mpagama, S. G., van den Boogaard, J., Sumari-de Boer, I. M., Magis-Escurra, C., Wattenberg, M., Logger, J. G. M., te Brake, L. H. M., Hoelscher, M., Gillespie, S. H., Colbers, A., Phillips, P. P. J., Plemper van Balen, G., Boeree, M. J. & PanACEA Consortium 1 Nov 2017 In : Antimicrobial Agents and Chemotherapy. 61, 11, e01054-17

    Research output: Contribution to journalArticle

  5. Spot sputum samples are at least as good as early morning samples for identifying Mycobacterium tuberculosis

    Murphy, M. E., Phillips, P. P. J., Mendel, C. M., Bongard, E., Bateson, A. L. C., Hunt, R., Murthy, S., Singh, K. P., Brown, M., Crook, A. M., Nunn, A. J., Meredith, S. K., Lipman, M., McHugh, T. D., Gillespie, S. H. & on behalf of the REMoxTB Consortium 27 Oct 2017 In : BMC Medicine. 15, 10 p., 192

    Research output: Contribution to journalArticle

Related by journal

  1. Has primary care antimicrobial use really been increasing? Comparison of changes in different prescribing measures for a complete geographic population 1995–2014

    Neilly, M. D. J., Guthrie, B., Hernandez Santiago, V., Vadiveloo, T., Donnan, P. T. & Marwick, C. A. 1 Oct 2017 In : Journal of Antimicrobial Chemotherapy. 72, 10, p. 2921-2930 10 p.

    Research output: Contribution to journalArticle

  2. Improved power for TB phase IIa trials using a model-based pharmacokinetic-pharmacodynamic approach compared with commonly used analysis methods

    Svensson, R. J., Gillespie, S. H. & Simonsson, U. S. H. 1 Aug 2017 In : Journal of Antimicrobial Chemotherapy. 72, 8, p. 2311-2319 9 p.

    Research output: Contribution to journalArticle

  3. ST3268: a geographically widespread primate MRSA clone

    Hsu, L-Y., Holden, M. T. G., Koh, T. H., Pettigrew, K. A., Cao, D., Hon, P. Y., Sergio, D. M., Pena, E. & Ogden, B. E. 1 Aug 2017 In : Journal of Antimicrobial Chemotherapy. 72, 8, p. 2401-2403 2 p.

    Research output: Contribution to journalLetter

  4. Time series analysis of the impact of an intervention in Tayside, Scotland to reduce primary care broad-spectrum antimicrobial use

    Hernandez-Santiago, V., Marwick, C. A., Patton, A., Davey, P. G., Donnan, P. T. & Guthrie, B. 1 Aug 2015 In : Journal of Antimicrobial Chemotherapy. 70, 8, p. 2397-2404 8 p., dkv095

    Research output: Contribution to journalArticle

ID: 194099904